Andrew W. replied to a question that patients in t
Post# of 72440
Posted On: 11/20/2012 2:16:12 PM
Andrew W. replied to a question that patients in the study keep receiving Kevetrin as long as they want but that they only get the dosage they started with so patients in Cohort 1 will only get the low dose throughout the length of the trials.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼